Rahul Aggarwal, M.D.

GGenitourinary cancer and developmental therapeutics specialist

Dr. Rahul Aggarwal is a genitourinary cancer specialist at the UCSF Helen Diller Family Comprehensive Cancer Center. He also serves as director of the UCSF STAND (Supportive Therapy in Androgen Deprivation) Clinic, which provides comprehensive care to men with prostate cancer who are receiving androgen deprivation therapy, also known as hormone therapy. In addition, as a member of the Developmental Therapeutics Genitourinary Cancer Program, Aggarwal enrolls patients with advanced solid tumor malignancies into early phase clinical trials of novel targeted treatments. His research is focused on developing novel hormonal treatment strategies that reduce the toxicity of androgen deprivation therapy for men with advanced prostate cancer. Aggarwal is also interested in developing novel molecular imaging techniques as a prognostic and predictive biomarker of tumor response among patients with advanced solid tumors.

Aggarwal earned a medical degree from Northwestern University Feinberg School of Medicine. Subsequently, he completed an internship and residency in internal medicine followed by a clinical fellowship in hematology/oncology at UCSF. Aggarwal was also a research fellow in developmental therapeutics at Genentech, Inc. in South San Francisco. He is a member of the American Society of Clinical Oncology (ASCO) and recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award. Aggarwal is an assistant clinical professor of medicine at UCSF.

1600 Divisadero Street, 3rd Floor
San Francisco, CA 94143
Phone: (415) 885-7795
Fax: (415) 353-7093

Urologic Surgery and Oncology
1600 Divisadero St., Third Floor
San Francisco, CA 94115
Phone: (415) 353-7171
Fax: (415) 353-7093

Hours: Monday to Friday
8 a.m. – 5 p.m.